Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study.

Wilding, J P H; Ferrannini, E; Fonseca, V A; Wilpshaar, W; Dhanjal, P; Houzer, A

Wilding, J P H; Ferrannini, E; Fonseca, V A; Wilpshaar, W; Dhanjal, P; Houzer, A.

Affiliation

Wilding JP; Department of Obesity and Endocrinology, Clinical Sciences Centre, University of Liverpool, University Hospital Aintree, Liverpool, UK. j.p.h.wilding@liv.ac.uk

Diabetes Obes Metab ; 15(5): 403-9, 2013 May.

Article in En | MEDLINE | ID: mdl-23163880

Subject(s)

Blood Glucose/metabolism; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/drug therapy; Glucosides/administration & dosage; Glycated Hemoglobin/metabolism; Hypoglycemic Agents/administration & dosage; Metformin/administration & dosage; Thiophenes/administration & dosage; Biomarkers/blood; Diabetes Mellitus, Type 2/epidemiology; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Europe/epidemiology; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Blood Glucose / Glycated Hemoglobin / Diabetes Mellitus, Type 2 / Glucosides / Hypoglycemic Agents / Metformin Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Europa Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google